Impact of physical activity on sleep quality for people with alcohol use disorder
Official title: Study of Adapted Physical Activity's Impact on Sleep's Quality in Alcohol-use Disorder
Run by Centre Hospitalier Universitaire de Besancon · NCT06706349 · Data updated 2026-11-12
This study is testing whether a supervised exercise program can help improve sleep quality for people struggling with alcohol use disorder.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Centre Hospitalier Universitaire de Besancon Academic / other |
| Locations | 1 site (Besançon) |
| Status | Recruiting |
| Started | October 17, 2024 |
| Main results expected | October 2027 |
| Study ends | October 2027 |
| Registry record updated | February 12, 2026 |
| Trial ID | NCT06706349 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 65 with a diagnosis of Alcohol Use Disorder and sleep complaints.
✕Probably not a fit
Patients who do not have sleep complaints or are not actively consuming alcohol may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This feasibility study evaluates the interest, recruitment, and adherence to a supervised physical activity program among individuals with Alcohol Use Disorder (AUD). It aims to assess the program's effects on sleep quality and efficiency, focusing on recruitment feasibility, randomization acceptance, and adherence rates. Participants will engage in adapted physical activity sessions and complete various sleep assessments, including sleep diaries and psychometric scales, to determine the potential benefits of physical activity on sleep outcomes in AUD patients.
Why it matters
Potential benefit: If successful, this study could improve sleep quality for individuals suffering from Alcohol Use Disorder.
How similar studies have gone: While this approach is novel in the context of AUD, similar studies have shown that physical activity can positively impact sleep quality in various populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects aged 18 to 65 years inclusive * Present an Alcohol Use Disorder (AUD) with at least 2 positive items as defined by the DSM-5 * Present a sleep complaint with a score on the Pittsburgh Sleep Quality Index (PSQI) ≥ 5 * Present active alcohol consumption with at least 6 days of excessive alcohol consumption in the last 4 weeks * Speak and understand French * Live within 30 minutes of the University Hospital of Besançon * Treatment allowed if stabilized for at least 4 weeks * Signature of informed consent indicating that the subject has understood the purpose and procedures required by the study and agrees to participate and comply with the requirements and restrictions inherent to the study * Signed automobile safety contract: 1. The participant agrees to hand over the keys to their vehicle if necessary. 2. The keys will be returned when the blood alcohol level is below 0.25 mg/L 3. The participant agrees to name one or more people to contact in case the medical staff deems the participant unfit to return home alone. * Affiliation to a French social security system or beneficiary of such a system * Postmenopausal women for at least 24 months, surgically sterilized, or, for women of childbearing age, using an effective method of contraception (oral contraceptives, contraceptive injections, intrauterine devices, double-barrier method, contraceptive patches) (self-reported) Exclusion Criteria: * Decompensated heart failure * Complex ventricular arrhythmias * Severe uncontrolled hypertension * Pulmonary hypertension (\>60 mmHg) * Myocarditis or acute pericardial effusion * Severe obstructive cardiomyopathy * Severe and/or symptomatic aortic stenosis * All acute illnesses * All decompensated or unstable chronic conditions * Significant malnutrition * Extreme fatigue and/or manifest physical incapacity * Severe anemia * Severe intoxication (psychoactive substances) * Severe withdrawal syndrome (Cushman \>7) * Relative contraindications for high-intensity physical activities: * Chronic respiratory insufficiency on long-term oxygen * Severe chronic respiratory conditions * Complicated diabetes with severe retinopathy * Sickle cell disease * Mild intoxication (psychoactive substances) * Mild withdrawal syndrome (Cushman \>2) * Musculoskeletal and dermatological limitations: Unhealed traumatic injuries. * Musculoskeletal and dermatological limitations: Osteoarticular conditions in acute flare (osteoarthritis, arthritis). * Musculoskeletal and dermatological limitations: Diabetes with plantar ulcer. * Musculoskeletal and dermatological limitations: Pressure ulcers and evolving or chronic wounds. * On the day of signing consent: Blood alcohol concentration \> 0 mg/L of expired air. * On the day of signing consent: If blood alcohol concentration is \< 0.25 mg/L, the participant may join other therapeutic activities and return home autonomously. * On the day of signing consent: If blood alcohol concentration is \> 0.25 mg/L without clinical signs of intoxication, the participant may join other therapeutic activities and return home accompanied. * On the day of signing consent: If blood alcohol concentration is \> 0.25 mg/L with clinical signs of intoxication, the participant will not join other therapeutic activities. A supervised room placement will be offered, and emergency services may be contacted if intoxication is unusually high (\>2 g/L). * Excessive alcohol consumption ≥ 6 days in the 4 weeks prior to inclusion. * Average alcohol consumption \> 20 g/day or \> 100 g/week. * CIWA score ≥ 9, indicating the need for medication-assisted withdrawal. * High physical activity levels according to the Global Physical Activity Questionnaire (GPAQ). * Concurrent treatment with disulfiram, melatonin, and beta-blockers. * Unstable or recently changed treatments (\<4 weeks). * History of pre-delirium tremens or delirium tremens. * Substance use disorder (other than alcohol/nicotine per DSM-5). * Acute psychiatric disorders requiring immediate hospitalization or adjustment of psychotropic medications. * Advanced somatic disorders contraindicating physical activity. * Lack of signed automobile safety contract. * Legal incapacity or refusal to sign consent. * No health insurance. * Anticipated poor cooperation or difficulty completing the study * Pregnant or breastfeeding women. * Currently in the exclusion period of another study or listed in the national volunteer registry.
Where it's running
-
CHU de Besançon
Besançon, France Recruiting
Study contacts
- Principal investigator: Julie GIUSTINIANI, MD — CHU Besançon
- Study coordinator: Karine CHARRIERE, PhD
- Email: kcharriere@chu-besancon.fr
- Phone: + 33381218999
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Emotional Reactivity in Severe Alcohol Use Disorder and Depression Using Eye-Tracking and Physiological Measures
This study tests how people with severe alcohol use disorder, major depressive disorder, both conditions, or neither, recognize and react to emotions using eye-tracking and physiological data.
-
Thiamine to reduce brain injury in adults with alcohol use disorder
This trial tests whether thiamine can help protect the brain in adults with moderate to severe alcohol use disorder who drink daily.
-
Digital Recovery Support for Black adults with Alcohol Use Disorder in Detroit
This study tests whether a smartphone-based digital recovery program helps Black or African American adults in Detroit maintain their recovery from alcohol use disorder.
-
Path180: a computer-based skills program to help teens reduce alcohol use
This 8-week trial tests Path180, a computer-based skills training, added to usual care for teens 13–19 with alcohol use disorder to see if it improves daily-life coping skills and outcomes.
-
Effects of comorbidity on people with severe mental illness
This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.
-
Psilocybin in Alcohol Use Disorder with Depression (Relapse Prevention)
This study tests whether higher-dose psilocybin-assisted psychotherapy helps prevent relapse in adults with severe alcohol use disorder and depressive symptoms after detox.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.